Muhammad Bilal/LinkedIn
Mar 13, 2026, 16:36
Muhammad Bilal: Principles and Clinical Uses of the Coombs Test
Muhammad Bilal, Medical Laboratory Technologist at Malak Laboratory Timergara, shared a post on LinkedIn:
“Coombs Test (Antiglobulin Test)
1. Objective
The objective of this test was to detect antibodies directed against red blood cells.
2. Principle
The test was based on the reaction between anti-human globulin (Coombs reagent) and antibodies attached to red blood cells. Agglutination indicated a positive result.
3. Materials
- Blood sample
- Coombs reagent (Anti-human globulin)
- Test tubes
- Centrifuge
- Normal saline
- Microscope
4. Procedure
- Blood was collected under aseptic conditions.
- Red blood cells were washed with normal saline.
- Coombs reagent was added to the cell suspension.
- The mixture was centrifuged.
- The tube was examined for agglutination.
5. Result
- A positive result indicates that agglutination was observed.
- A negative result indicates that no agglutination was observed.
6. Uses
- It was used to diagnose hemolytic anemia.
- It helped detect autoimmune reactions.
- It assisted in compatibility testing.
- It was useful in hemolytic disease of the newborn.
7. Consultation
The result was interpreted by a clinician along with clinical findings and other hematological tests.”

Stay updated with Hemostasis Today.
-
Oct 10, 2026, 09:05Wolfgang Miesbach: Moving from Bleed Control to Comprehensive Joint Health
-
Oct 10, 2026, 07:59Leila Caroline Souza Reis: Enoxaparin Dosing for VTE Prevention in Adults With Obesity
-
Oct 10, 2026, 07:41Adeeb Bazuhair: New Evidence for Catheter Directed Thrombolysis in Acute PE
-
Oct 10, 2026, 07:22Poppy Clarke: Turning Steps Into Support for Thrombosis Awareness
-
Oct 10, 2026, 07:12Hamzah Khan: The Role of Genuine Curiosity in Driving High-Impact Academic Research
-
Oct 10, 2026, 06:58Nita Radhakrishnan: Turning Evidence Into Action for Hemophilia Care in India
-
Oct 10, 2026, 06:48Nutan Kaushik: HemeNext 2.0 Brings Global Perspectives to Hematology
-
Oct 10, 2026, 06:43Suthesh Sivapalaratnam: Advancing Bleeding Disorder Care at EHC 2026
-
Oct 10, 2026, 02:38Brianne D.: Sex Differences in RIPK1 Signaling Following Intracerebral Hemorrhage